Caseware UK (AP4) 2024.0.164 2024.0.164 2025-09-302025-09-302026-05-31false2024-10-01falseSpecialists medical practice activities22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12221500 2024-10-01 2025-09-30 12221500 2023-10-01 2024-09-30 12221500 2025-09-30 12221500 2024-09-30 12221500 c:Director2 2024-10-01 2025-09-30 12221500 d:FurnitureFittings 2024-10-01 2025-09-30 12221500 d:FurnitureFittings 2025-09-30 12221500 d:FurnitureFittings 2024-09-30 12221500 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-10-01 2025-09-30 12221500 d:CurrentFinancialInstruments 2025-09-30 12221500 d:CurrentFinancialInstruments 2024-09-30 12221500 d:CurrentFinancialInstruments d:WithinOneYear 2025-09-30 12221500 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 12221500 d:ShareCapital 2025-09-30 12221500 d:ShareCapital 2024-09-30 12221500 d:RetainedEarningsAccumulatedLosses 2025-09-30 12221500 d:RetainedEarningsAccumulatedLosses 2024-09-30 12221500 d:AcceleratedTaxDepreciationDeferredTax 2025-09-30 12221500 d:AcceleratedTaxDepreciationDeferredTax 2024-09-30 12221500 c:FRS102 2024-10-01 2025-09-30 12221500 c:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 12221500 c:FullAccounts 2024-10-01 2025-09-30 12221500 c:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 12221500 2 2024-10-01 2025-09-30 12221500 e:PoundSterling 2024-10-01 2025-09-30 iso4217:GBP xbrli:pure

Registered number:  12221500














MY UPPER LIMB SURGEON LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025


 
MY UPPER LIMB SURGEON LIMITED
REGISTERED NUMBER: 12221500

BALANCE SHEET
AS AT 30 SEPTEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
9,891
10,765

  
9,891
10,765

Current assets
  

Debtors: amounts falling due within one year
 5 
232,063
231,684

Cash at bank and in hand
 6 
139,407
124,059

  
371,470
355,743

Creditors: amounts falling due within one year
 7 
(29,801)
(78,493)

Net current assets
  
 
 
341,669
 
 
277,250

Total assets less current liabilities
  
351,560
288,015

Provisions for liabilities
  

Deferred tax
 8 
(2,473)
(2,691)

  
 
 
(2,473)
 
 
(2,691)

Net assets
  
349,087
285,324


Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
349,085
285,322

  
349,087
285,324


Page 1

 
MY UPPER LIMB SURGEON LIMITED
REGISTERED NUMBER: 12221500
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




S D Brookes-Fazakerley
Director

Date: 31 May 2026

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

1.


General information

My Upper Limb Surgeon Limited is a private company limited by shares incorporated in Engalnd and Wales under the Companies Act 2006; the company number is 12221500. The address of the registered office is C/O Langtons, The Plaza, 100 Old Hall Street, Liverpool, L3 9QJ. 
These financial statements present information about the company as an individual undertaking; it is not a member of a group of companies. The principal activity of the company is that of specialist medical practice activities.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

2.Accounting policies (continued)

 
2.4

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 4

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

2.Accounting policies (continued)

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).

Page 5

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

4.


Tangible fixed assets





Fixtures and fittings

£



Cost or valuation


At 1 October 2024
13,510


Additions
2,151



At 30 September 2025

15,661



Depreciation


At 1 October 2024
2,745


Charge for the year on owned assets
3,025



At 30 September 2025

5,770



Net book value



At 30 September 2025
9,891



At 30 September 2024
10,765


5.


Debtors

2025
2024
£
£


Other debtors
173,664
173,285

Tax recoverable
58,399
58,399

232,063
231,684



6.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
139,407
124,059

139,407
124,059


Page 6

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Corporation tax
28,436
77,442

Accruals and deferred income
1,365
1,051

29,801
78,493



8.


Deferred taxation




2025


£






At beginning of year
(2,691)


Charged to profit or loss
218



At end of year
(2,473)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
(2,473)
(2,691)

(2,473)
(2,691)


9.


Related party transactions


2025
2024
£
£

S Brookes-Fazakerley
68,662
69,451
D Brookes-Fazakerley
105,002
103,834
173,664
173,285

S Brookes-Fazakerley and D Brookes-Fazakerley are both directors of the company. The loans are repayable on demand. Interest has been charged at 2.25%. 

Page 7

 
MY UPPER LIMB SURGEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

10.


Controlling party

The company is controlled by its directors.

 
Page 8